Activated Protein C and Corticosteroids for Human Septic Shock
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study aims at comparing the efficacy and safety of recombinant human activated protein C
to that of low dose of corticosteroids and at investigating the interaction between these
drugs in the management of septic shock
Phase:
Phase 3
Details
Lead Sponsor:
University of Versailles
Collaborators:
Assistance Publique - Hôpitaux de Paris Ministry of Health, France
Treatments:
Cortisol succinate Drotrecogin alfa activated Fludrocortisone Hydrocortisone Hydrocortisone 17-butyrate 21-propionate Hydrocortisone acetate Hydrocortisone hemisuccinate Protein C